Generate a tailored SOP for Dr. Manal Elnenaei. Improve your application with a focused, well-structured draft.
Manal Elnenaei has been instrumental in developing the leading Myeloma Tumor Bank initiative, which integrates a multidisciplinary team of Dalhousie Faculty Clinician Scientists focused on translational research in Multiple Myeloma. Her research objectives aim to enhance clinical genetics and immunology studies, creating accurate models of cancer and testing novel treatment modalities in precision medicine. Dr. Elnenaei collaborates closely with the endocrine team on clinical research projects involving testing protocols that comply with local guidelines. Her interest in appropriate test utilization has led to significant savings by reducing unnecessary laboratory tests, as evidenced by her involvement in the NSHA Choosing Wisely group. Furthermore, she works with the Dalhousie Health Informatics team to broaden the impact of healthcare initiatives. Dr. Elnenaei holds multiple qualifications, including European Specialist in Laboratory Medicine and a PhD in Pathology from the University of London, where she studied the genetic characterization of Multiple Myeloma. Additionally, she is engaged in teaching and mentoring medical students, General Pathology and Hematopathology residents, and has contributed extensively to clinical and research activities within the Faculty of Medicine.